共 50 条
- [3] Adjuvant checkpoint inhibitor trials: Is disease-free survival an appropriate endpoint? JOURNAL OF CANCER POLICY, 2023, 35
- [8] Middle lobe tumors and lymphovascular invasion as independent predictors of recurrence-free survival in stage I NSCLC BMC PULMONARY MEDICINE, 2025, 25 (01):
- [10] A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival International Urology and Nephrology, 2017, 49 : 825 - 835